Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.
Clinical trial NCT04925674 · COMPLETED
Trial details
- NCT number
- NCT04925674
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2022-10-19
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.